Evidence map›Paper›PMID 36133153›Full record

ReviewFrontiers in pain research (Lausanne, Switzerland)2022

The beneficial role of companion animals in translational pain research.

B Duncan X Lascelles, Dottie C Brown, Michael G Conzemius, Marie Gill, Michael L Oshinsky, Michelle Sharkey

Abstract readReview
In one paragraph

Review in Frontiers in pain research (Lausanne, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

B Duncan X LascellesTranslational Research in Pain, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States.
Dottie C BrownGlobal Efficacy & Model Development, Elanco Animal Health, Greenfield, IN, United States.
Michael G ConzemiusClinical Investigation Center, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, United States.
Marie GillNational Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, MD, United States.
Michael L OshinskyNational Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, MD, United States.
Michelle SharkeyCenter for Veterinary Medicine Food and Drug Administration, Rockville, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of spontaneous painful disease in companion pet animals has been highlighted as one of the changes that could be made to help improve translation of basic science to new therapeutics, acting as a bridge between preclinical and clinical studies, with the goal of accelerating the approval of new therapeutics. This review focuses on the utility of companion pet dogs for translational research by reviewing what outcome measures can be measured, and importantly, the relevance of these outcome measures to human translational research. It also details the practical considerations involved in incorporating companion dogs into human therapeutic development.

Indexed as

caninedrug develoment processmodelpaintranslational

Identifiers

PMID36133153
PMCPMC9483146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.